Tuesday, October 6, 2020

Trump’s course of treatment


The President may be the only person in the country on this very specific treatment plan for Covid-19. Of course, as the commander-in-chief, doctors are treating him with the hope of relieving his Covid-19 symptoms and possibly shortening his course of illness.


As some experts put it, doctors are throwing "the kitchen sink" at him. Here’s what we know about the treatments he is getting:


Trump received a monoclonal antibody cocktail, an investigational immune system treatment from the biotechnology company Regeneron. To make its monoclonal antibody therapy, Regeneron scientists selected two antibodies that best neutralized a version of the novel coronavirus in the lab. Antibodies are proteins the body makes to fight infection. The scientists copied those two antibodies to make a treatment for Covid-19.


President Trump is also receiving a five-day course of the antiviral drug remdesivir. His doctors said he would get the fourth dose before leaving Walter Reed on Monday, and he would receive the fifth dose at the White House. The treatment is intended to shorten recovery time for Covid-19 patients.


President Trump was given the corticosteroid drug dexamethasone on Saturday after his oxygen level transiently dipped, White House physician Dr. Sean Conley said.


Trump has also taken zinc, vitamin D, the heartburn drug famotidine, melatonin and a daily aspirin. Some small studies have indicated famotidine, the active ingredient in Pepcid AC, might help improve recovery from Covid-19 but it wasn't clear if that's why Trump took it.


There are some questions about the short- and long-term impact of Trump’s course of treatment. Most patients with coronavirus would not receive or have access to this combination of treatment, and therefore there are few studies about the impact taking them all together could have. Medical experts have suggested the combination of experimental treatments and therapies Trump received would be mostly out of reach for anyone except the President.

No comments:

Post a Comment